Goldline Pharmac

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1CLW01015
  • NSEID:
  • BSEID: 544759
INR
40.09
0.00 (0.00%)
BSENSE

Aug 18, 04:00 PM

BSE+NSE Vol: 3000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 11.20% vs 19.05% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 19.00% vs 35.53% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -23.72% vs 6.92% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 45.26% vs 56.94% in Mar 2025

Compare Profit and Loss Results of Goldline Pharmac
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
31.00
854.00
-823.00
-96.37%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
31.00
854.00
-823.00
-96.37%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
10.00
-10.00
-100.00%
Raw Materials Consumed
10.00
830.00
-820.00
-98.80%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
7.00
0.00
7.00
0%
Operating Expenses
0.00
1.00
-1.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
0.00
5.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
24.00
844.00
-820.00
-97.16%
Operating Profit (PBDIT) excl Other Income
6.00
10.00
-4.00
-40.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
6.00
10.00
-4.00
-40.00%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
5.00
10.00
-5.00
-50.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
5.00
10.00
-5.00
-50.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
10.00
-5.00
-50.00%
Provision for Tax
1.00
2.00
-1.00
-50.00%
Profit After Tax
4.00
7.00
-3.00
-42.86%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1.00
4.00
-3.00
-75.00%
Profit Available for appropriations
5.00
11.00
-6.00
-54.55%
Appropriations
5.00
11.00
-6.00
-54.55%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
5.97
0.04
5.93
14,825.00%
Profit And Loss - Net Sales
Net Sales 31.20 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.20% vs 19.05% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.94 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 19.00% vs 35.53% in Mar 2025

Profit And Loss - Interest
Interest 1.31 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -23.72% vs 6.92% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 4.12 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 45.26% vs 56.94% in Mar 2025